Nanotoxicology plays a pivotal role in revolutionizing diagnostics within the pharmaceutical industry. With the advent of nanotechnology, the development and utilization of nanomaterials in diagnostic applications have surged. These nano-sized materials exhibit unique properties that enable precise interactions at the molecular and cellular levels. In the realm of diagnosis, nanotoxicology becomes crucial for evaluating the potential adverse effects of these nanomaterials on living organisms. Understanding the toxicity of nanoparticles is paramount to ensuring the safety and efficacy of diagnostic tools.
Researchers are investigating the interactions between nanoparticles and biological systems, exploring how these interactions might influence cellular functions. By comprehensively studying nanotoxicity, the pharmaceutical industry can design and implement innovative diagnostic strategies that leverage the advantages of nanomaterials while minimizing potential risks to patients. This interdisciplinary approach, combining nanotechnology and toxicology, not only propels advancements in diagnostic precision but also underscores the commitment to patient safety in the ever-evolving landscape of pharmaceutical innovation.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico